nodes	percent_of_prediction	percent_of_DWPC	metapath
Etoposide—GSTP1—amyotrophic lateral sclerosis	0.386	0.76	CbGaD
Etoposide—ABCG2—Riluzole—amyotrophic lateral sclerosis	0.255	0.708	CbGbCtD
Etoposide—PTGS2—amyotrophic lateral sclerosis	0.122	0.24	CbGaD
Etoposide—CYP1A2—Riluzole—amyotrophic lateral sclerosis	0.105	0.292	CbGbCtD
Etoposide—Podofilox—TUBA4A—amyotrophic lateral sclerosis	0.00743	1	CrCbGaD
Etoposide—Anorectal discomfort—Riluzole—amyotrophic lateral sclerosis	0.0032	0.0417	CcSEcCtD
Etoposide—Cyanosis—Riluzole—amyotrophic lateral sclerosis	0.00247	0.0322	CcSEcCtD
Etoposide—Interstitial lung disease—Riluzole—amyotrophic lateral sclerosis	0.00247	0.0322	CcSEcCtD
Etoposide—Apnoea—Riluzole—amyotrophic lateral sclerosis	0.00206	0.0269	CcSEcCtD
Etoposide—Cellulitis—Riluzole—amyotrophic lateral sclerosis	0.00192	0.0251	CcSEcCtD
Etoposide—Ulcer—Riluzole—amyotrophic lateral sclerosis	0.00185	0.0241	CcSEcCtD
Etoposide—Phosphatase alkaline increased—Riluzole—amyotrophic lateral sclerosis	0.00175	0.0228	CcSEcCtD
Etoposide—Candida infection—Riluzole—amyotrophic lateral sclerosis	0.00167	0.0218	CcSEcCtD
Etoposide—TOP2B—hindbrain—amyotrophic lateral sclerosis	0.00158	0.0864	CbGeAlD
Etoposide—Sepsis—Riluzole—amyotrophic lateral sclerosis	0.00152	0.0198	CcSEcCtD
Etoposide—Phlebitis—Riluzole—amyotrophic lateral sclerosis	0.00147	0.0192	CcSEcCtD
Etoposide—Blood alkaline phosphatase increased—Riluzole—amyotrophic lateral sclerosis	0.00146	0.019	CcSEcCtD
Etoposide—Cardiac failure congestive—Riluzole—amyotrophic lateral sclerosis	0.0014	0.0182	CcSEcCtD
Etoposide—Anaphylactoid reaction—Riluzole—amyotrophic lateral sclerosis	0.00131	0.0171	CcSEcCtD
Etoposide—Cardiac failure—Riluzole—amyotrophic lateral sclerosis	0.0013	0.017	CcSEcCtD
Etoposide—Cardiac arrest—Riluzole—amyotrophic lateral sclerosis	0.00121	0.0157	CcSEcCtD
Etoposide—Alanine aminotransferase increased—Riluzole—amyotrophic lateral sclerosis	0.00112	0.0146	CcSEcCtD
Etoposide—Dysphagia—Riluzole—amyotrophic lateral sclerosis	0.0011	0.0143	CcSEcCtD
Etoposide—Pancytopenia—Riluzole—amyotrophic lateral sclerosis	0.00104	0.0136	CcSEcCtD
Etoposide—Neutropenia—Riluzole—amyotrophic lateral sclerosis	0.00103	0.0134	CcSEcCtD
Etoposide—PTGS2—hindlimb—amyotrophic lateral sclerosis	0.00101	0.0554	CbGeAlD
Etoposide—TOP2B—embryo—amyotrophic lateral sclerosis	0.000989	0.054	CbGeAlD
Etoposide—Pneumonia—Riluzole—amyotrophic lateral sclerosis	0.000983	0.0128	CcSEcCtD
Etoposide—Infestation—Riluzole—amyotrophic lateral sclerosis	0.000978	0.0127	CcSEcCtD
Etoposide—Infestation NOS—Riluzole—amyotrophic lateral sclerosis	0.000978	0.0127	CcSEcCtD
Etoposide—Acute coronary syndrome—Riluzole—amyotrophic lateral sclerosis	0.000964	0.0126	CcSEcCtD
Etoposide—Myocardial infarction—Riluzole—amyotrophic lateral sclerosis	0.000958	0.0125	CcSEcCtD
Etoposide—Neuropathy peripheral—Riluzole—amyotrophic lateral sclerosis	0.000958	0.0125	CcSEcCtD
Etoposide—Stomatitis—Riluzole—amyotrophic lateral sclerosis	0.000953	0.0124	CcSEcCtD
Etoposide—Jaundice—Riluzole—amyotrophic lateral sclerosis	0.000953	0.0124	CcSEcCtD
Etoposide—Hepatobiliary disease—Riluzole—amyotrophic lateral sclerosis	0.000925	0.0121	CcSEcCtD
Etoposide—Agranulocytosis—Riluzole—amyotrophic lateral sclerosis	0.000912	0.0119	CcSEcCtD
Etoposide—TOP2B—brainstem—amyotrophic lateral sclerosis	0.000906	0.0495	CbGeAlD
Etoposide—Hypoaesthesia—Riluzole—amyotrophic lateral sclerosis	0.000873	0.0114	CcSEcCtD
Etoposide—PTGS2—appendage—amyotrophic lateral sclerosis	0.00087	0.0476	CbGeAlD
Etoposide—Urinary tract disorder—Riluzole—amyotrophic lateral sclerosis	0.000867	0.0113	CcSEcCtD
Etoposide—Urethral disorder—Riluzole—amyotrophic lateral sclerosis	0.00086	0.0112	CcSEcCtD
Etoposide—Erythema multiforme—Riluzole—amyotrophic lateral sclerosis	0.00083	0.0108	CcSEcCtD
Etoposide—Eye disorder—Riluzole—amyotrophic lateral sclerosis	0.00082	0.0107	CcSEcCtD
Etoposide—Cardiac disorder—Riluzole—amyotrophic lateral sclerosis	0.000814	0.0106	CcSEcCtD
Etoposide—Angiopathy—Riluzole—amyotrophic lateral sclerosis	0.000796	0.0104	CcSEcCtD
Etoposide—Immune system disorder—Riluzole—amyotrophic lateral sclerosis	0.000793	0.0103	CcSEcCtD
Etoposide—Mediastinal disorder—Riluzole—amyotrophic lateral sclerosis	0.000791	0.0103	CcSEcCtD
Etoposide—Chills—Riluzole—amyotrophic lateral sclerosis	0.000787	0.0103	CcSEcCtD
Etoposide—Alopecia—Riluzole—amyotrophic lateral sclerosis	0.000775	0.0101	CcSEcCtD
Etoposide—Dysgeusia—Riluzole—amyotrophic lateral sclerosis	0.000748	0.00976	CcSEcCtD
Etoposide—Back pain—Riluzole—amyotrophic lateral sclerosis	0.000739	0.00964	CcSEcCtD
Etoposide—Muscle spasms—Riluzole—amyotrophic lateral sclerosis	0.000734	0.00958	CcSEcCtD
Etoposide—Ill-defined disorder—Riluzole—amyotrophic lateral sclerosis	0.000709	0.00924	CcSEcCtD
Etoposide—Anaemia—Riluzole—amyotrophic lateral sclerosis	0.000706	0.00921	CcSEcCtD
Etoposide—Malaise—Riluzole—amyotrophic lateral sclerosis	0.000689	0.00898	CcSEcCtD
Etoposide—Vertigo—Riluzole—amyotrophic lateral sclerosis	0.000686	0.00895	CcSEcCtD
Etoposide—Leukopenia—Riluzole—amyotrophic lateral sclerosis	0.000684	0.00892	CcSEcCtD
Etoposide—Loss of consciousness—Riluzole—amyotrophic lateral sclerosis	0.000671	0.00876	CcSEcCtD
Etoposide—Cough—Riluzole—amyotrophic lateral sclerosis	0.000667	0.00869	CcSEcCtD
Etoposide—Convulsion—Riluzole—amyotrophic lateral sclerosis	0.000662	0.00863	CcSEcCtD
Etoposide—Hypertension—Riluzole—amyotrophic lateral sclerosis	0.00066	0.0086	CcSEcCtD
Etoposide—Chest pain—Riluzole—amyotrophic lateral sclerosis	0.00065	0.00848	CcSEcCtD
Etoposide—Unspecified disorder of skin and subcutaneous tissue—Riluzole—amyotrophic lateral sclerosis	0.000646	0.00842	CcSEcCtD
Etoposide—GSTT1—nervous system—amyotrophic lateral sclerosis	0.000644	0.0352	CbGeAlD
Etoposide—Discomfort—Riluzole—amyotrophic lateral sclerosis	0.000643	0.00838	CcSEcCtD
Etoposide—TOP2B—medulla oblongata—amyotrophic lateral sclerosis	0.000632	0.0345	CbGeAlD
Etoposide—Confusional state—Riluzole—amyotrophic lateral sclerosis	0.000629	0.0082	CcSEcCtD
Etoposide—Anaphylactic shock—Riluzole—amyotrophic lateral sclerosis	0.000623	0.00813	CcSEcCtD
Etoposide—Infection—Riluzole—amyotrophic lateral sclerosis	0.000619	0.00808	CcSEcCtD
Etoposide—GSTP1—embryo—amyotrophic lateral sclerosis	0.000619	0.0339	CbGeAlD
Etoposide—Thrombocytopenia—Riluzole—amyotrophic lateral sclerosis	0.00061	0.00796	CcSEcCtD
Etoposide—Tachycardia—Riluzole—amyotrophic lateral sclerosis	0.000608	0.00794	CcSEcCtD
Etoposide—Skin disorder—Riluzole—amyotrophic lateral sclerosis	0.000606	0.0079	CcSEcCtD
Etoposide—Hyperhidrosis—Riluzole—amyotrophic lateral sclerosis	0.000603	0.00786	CcSEcCtD
Etoposide—Anorexia—Riluzole—amyotrophic lateral sclerosis	0.000594	0.00775	CcSEcCtD
Etoposide—Hypotension—Riluzole—amyotrophic lateral sclerosis	0.000583	0.0076	CcSEcCtD
Etoposide—TOP2B—spinal cord—amyotrophic lateral sclerosis	0.000563	0.0308	CbGeAlD
Etoposide—Paraesthesia—Riluzole—amyotrophic lateral sclerosis	0.00056	0.0073	CcSEcCtD
Etoposide—Dyspnoea—Riluzole—amyotrophic lateral sclerosis	0.000556	0.00725	CcSEcCtD
Etoposide—Somnolence—Riluzole—amyotrophic lateral sclerosis	0.000554	0.00723	CcSEcCtD
Etoposide—Decreased appetite—Riluzole—amyotrophic lateral sclerosis	0.000542	0.00707	CcSEcCtD
Etoposide—Gastrointestinal disorder—Riluzole—amyotrophic lateral sclerosis	0.000538	0.00702	CcSEcCtD
Etoposide—Fatigue—Riluzole—amyotrophic lateral sclerosis	0.000538	0.00701	CcSEcCtD
Etoposide—Pain—Riluzole—amyotrophic lateral sclerosis	0.000533	0.00695	CcSEcCtD
Etoposide—Constipation—Riluzole—amyotrophic lateral sclerosis	0.000533	0.00695	CcSEcCtD
Etoposide—Feeling abnormal—Riluzole—amyotrophic lateral sclerosis	0.000514	0.0067	CcSEcCtD
Etoposide—Gastrointestinal pain—Riluzole—amyotrophic lateral sclerosis	0.00051	0.00665	CcSEcCtD
Etoposide—Urticaria—Riluzole—amyotrophic lateral sclerosis	0.000495	0.00646	CcSEcCtD
Etoposide—Abdominal pain—Riluzole—amyotrophic lateral sclerosis	0.000493	0.00643	CcSEcCtD
Etoposide—Body temperature increased—Riluzole—amyotrophic lateral sclerosis	0.000493	0.00643	CcSEcCtD
Etoposide—TOP2B—nervous system—amyotrophic lateral sclerosis	0.000475	0.0259	CbGeAlD
Etoposide—Hypersensitivity—Riluzole—amyotrophic lateral sclerosis	0.000459	0.00599	CcSEcCtD
Etoposide—TOP2B—central nervous system—amyotrophic lateral sclerosis	0.000457	0.025	CbGeAlD
Etoposide—Asthenia—Riluzole—amyotrophic lateral sclerosis	0.000447	0.00583	CcSEcCtD
Etoposide—TOP2B—cerebellum—amyotrophic lateral sclerosis	0.000447	0.0244	CbGeAlD
Etoposide—Pruritus—Riluzole—amyotrophic lateral sclerosis	0.000441	0.00575	CcSEcCtD
Etoposide—Diarrhoea—Riluzole—amyotrophic lateral sclerosis	0.000427	0.00556	CcSEcCtD
Etoposide—Dizziness—Riluzole—amyotrophic lateral sclerosis	0.000412	0.00538	CcSEcCtD
Etoposide—Vomiting—Riluzole—amyotrophic lateral sclerosis	0.000396	0.00517	CcSEcCtD
Etoposide—GSTP1—medulla oblongata—amyotrophic lateral sclerosis	0.000396	0.0216	CbGeAlD
Etoposide—ABCC10—medulla oblongata—amyotrophic lateral sclerosis	0.000395	0.0216	CbGeAlD
Etoposide—Rash—Riluzole—amyotrophic lateral sclerosis	0.000393	0.00513	CcSEcCtD
Etoposide—Dermatitis—Riluzole—amyotrophic lateral sclerosis	0.000393	0.00512	CcSEcCtD
Etoposide—Headache—Riluzole—amyotrophic lateral sclerosis	0.000391	0.00509	CcSEcCtD
Etoposide—Nausea—Riluzole—amyotrophic lateral sclerosis	0.00037	0.00483	CcSEcCtD
Etoposide—TOP2B—brain—amyotrophic lateral sclerosis	0.000363	0.0198	CbGeAlD
Etoposide—GSTP1—spinal cord—amyotrophic lateral sclerosis	0.000353	0.0193	CbGeAlD
Etoposide—ABCC10—spinal cord—amyotrophic lateral sclerosis	0.000353	0.0193	CbGeAlD
Etoposide—ABCC3—nervous system—amyotrophic lateral sclerosis	0.000299	0.0163	CbGeAlD
Etoposide—GSTP1—nervous system—amyotrophic lateral sclerosis	0.000297	0.0163	CbGeAlD
Etoposide—PTGS2—embryo—amyotrophic lateral sclerosis	0.000289	0.0158	CbGeAlD
Etoposide—ABCC3—central nervous system—amyotrophic lateral sclerosis	0.000287	0.0157	CbGeAlD
Etoposide—GSTP1—central nervous system—amyotrophic lateral sclerosis	0.000286	0.0156	CbGeAlD
Etoposide—GSTP1—cerebellum—amyotrophic lateral sclerosis	0.00028	0.0153	CbGeAlD
Etoposide—ABCC10—cerebellum—amyotrophic lateral sclerosis	0.00028	0.0153	CbGeAlD
Etoposide—ABCG2—medulla oblongata—amyotrophic lateral sclerosis	0.000232	0.0127	CbGeAlD
Etoposide—ABCC3—brain—amyotrophic lateral sclerosis	0.000228	0.0125	CbGeAlD
Etoposide—GSTP1—brain—amyotrophic lateral sclerosis	0.000227	0.0124	CbGeAlD
Etoposide—ABCC10—brain—amyotrophic lateral sclerosis	0.000227	0.0124	CbGeAlD
Etoposide—ABCG2—spinal cord—amyotrophic lateral sclerosis	0.000206	0.0113	CbGeAlD
Etoposide—CYP2E1—medulla oblongata—amyotrophic lateral sclerosis	0.0002	0.011	CbGeAlD
Etoposide—ABCC1—cerebellum—amyotrophic lateral sclerosis	0.000198	0.0108	CbGeAlD
Etoposide—PTGS2—medulla oblongata—amyotrophic lateral sclerosis	0.000185	0.0101	CbGeAlD
Etoposide—CYP2E1—spinal cord—amyotrophic lateral sclerosis	0.000179	0.00977	CbGeAlD
Etoposide—ABCB1—embryo—amyotrophic lateral sclerosis	0.000179	0.00977	CbGeAlD
Etoposide—PTGS1—spinal cord—amyotrophic lateral sclerosis	0.000172	0.00941	CbGeAlD
Etoposide—PTGS2—spinal cord—amyotrophic lateral sclerosis	0.000165	0.009	CbGeAlD
Etoposide—ABCG2—cerebellum—amyotrophic lateral sclerosis	0.000164	0.00895	CbGeAlD
Etoposide—ABCC1—brain—amyotrophic lateral sclerosis	0.000161	0.00878	CbGeAlD
Etoposide—CYP2E1—nervous system—amyotrophic lateral sclerosis	0.000151	0.00823	CbGeAlD
Etoposide—PTGS1—nervous system—amyotrophic lateral sclerosis	0.000145	0.00793	CbGeAlD
Etoposide—CYP2E1—central nervous system—amyotrophic lateral sclerosis	0.000145	0.00793	CbGeAlD
Etoposide—CYP2E1—cerebellum—amyotrophic lateral sclerosis	0.000142	0.00775	CbGeAlD
Etoposide—PTGS1—central nervous system—amyotrophic lateral sclerosis	0.00014	0.00764	CbGeAlD
Etoposide—PTGS2—nervous system—amyotrophic lateral sclerosis	0.000139	0.00758	CbGeAlD
Etoposide—CYP2C8—brain—amyotrophic lateral sclerosis	0.000137	0.00748	CbGeAlD
Etoposide—PTGS2—central nervous system—amyotrophic lateral sclerosis	0.000134	0.0073	CbGeAlD
Etoposide—ABCG2—brain—amyotrophic lateral sclerosis	0.000133	0.00727	CbGeAlD
Etoposide—PTGS2—cerebellum—amyotrophic lateral sclerosis	0.000131	0.00714	CbGeAlD
Etoposide—CYP3A4—nervous system—amyotrophic lateral sclerosis	0.000121	0.00663	CbGeAlD
Etoposide—CYP3A4—central nervous system—amyotrophic lateral sclerosis	0.000117	0.00638	CbGeAlD
Etoposide—CYP2E1—brain—amyotrophic lateral sclerosis	0.000115	0.00629	CbGeAlD
Etoposide—ABCB1—medulla oblongata—amyotrophic lateral sclerosis	0.000114	0.00624	CbGeAlD
Etoposide—PTGS1—brain—amyotrophic lateral sclerosis	0.000111	0.00606	CbGeAlD
Etoposide—PTGS2—brain—amyotrophic lateral sclerosis	0.000106	0.0058	CbGeAlD
Etoposide—ABCB1—spinal cord—amyotrophic lateral sclerosis	0.000102	0.00557	CbGeAlD
Etoposide—ABCB1—nervous system—amyotrophic lateral sclerosis	8.58e-05	0.00469	CbGeAlD
Etoposide—ABCB1—central nervous system—amyotrophic lateral sclerosis	8.26e-05	0.00452	CbGeAlD
Etoposide—ABCB1—cerebellum—amyotrophic lateral sclerosis	8.07e-05	0.00441	CbGeAlD
Etoposide—ABCB1—brain—amyotrophic lateral sclerosis	6.56e-05	0.00359	CbGeAlD
Etoposide—ABCC1—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	3.83e-05	0.00127	CbGpPWpGaD
Etoposide—UGT1A1—Metabolism—SACM1L—amyotrophic lateral sclerosis	3.81e-05	0.00126	CbGpPWpGaD
Etoposide—ABCG2—Metabolism—VAPB—amyotrophic lateral sclerosis	3.8e-05	0.00126	CbGpPWpGaD
Etoposide—ABCG2—Metabolism—TPK1—amyotrophic lateral sclerosis	3.8e-05	0.00126	CbGpPWpGaD
Etoposide—GSTP1—Metabolism—CHAT—amyotrophic lateral sclerosis	3.71e-05	0.00122	CbGpPWpGaD
Etoposide—CYP3A4—Metapathway biotransformation—GSR—amyotrophic lateral sclerosis	3.7e-05	0.00122	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism of lipids and lipoproteins—VAPB—amyotrophic lateral sclerosis	3.69e-05	0.00122	CbGpPWpGaD
Etoposide—ABCC1—Metabolism—SACM1L—amyotrophic lateral sclerosis	3.68e-05	0.00121	CbGpPWpGaD
Etoposide—CYP1A2—Phase II conjugation—GSTP1—amyotrophic lateral sclerosis	3.66e-05	0.00121	CbGpPWpGaD
Etoposide—PTGS1—Metabolism—VAPB—amyotrophic lateral sclerosis	3.66e-05	0.00121	CbGpPWpGaD
Etoposide—PTGS1—Metabolism—TPK1—amyotrophic lateral sclerosis	3.66e-05	0.00121	CbGpPWpGaD
Etoposide—ABCB1—Integrated Pancreatic Cancer Pathway—IGFBP3—amyotrophic lateral sclerosis	3.65e-05	0.0012	CbGpPWpGaD
Etoposide—GSTT1—Metabolism—GSTP1—amyotrophic lateral sclerosis	3.64e-05	0.0012	CbGpPWpGaD
Etoposide—TOP2A—Integrated Pancreatic Cancer Pathway—CASP3—amyotrophic lateral sclerosis	3.61e-05	0.00119	CbGpPWpGaD
Etoposide—UGT1A1—Metabolism—FIG4—amyotrophic lateral sclerosis	3.58e-05	0.00118	CbGpPWpGaD
Etoposide—PTGS2—Metabolism of lipids and lipoproteins—PLB1—amyotrophic lateral sclerosis	3.57e-05	0.00118	CbGpPWpGaD
Etoposide—CYP2E1—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	3.56e-05	0.00118	CbGpPWpGaD
Etoposide—CYP3A5—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	3.56e-05	0.00117	CbGpPWpGaD
Etoposide—CYP2E1—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	3.52e-05	0.00116	CbGpPWpGaD
Etoposide—CYP3A5—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	3.51e-05	0.00116	CbGpPWpGaD
Etoposide—ABCG2—Metabolism—VAPA—amyotrophic lateral sclerosis	3.48e-05	0.00115	CbGpPWpGaD
Etoposide—PTGS2—Disease—TPK1—amyotrophic lateral sclerosis	3.46e-05	0.00114	CbGpPWpGaD
Etoposide—ABCC2—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	3.46e-05	0.00114	CbGpPWpGaD
Etoposide—ABCC1—Metabolism—FIG4—amyotrophic lateral sclerosis	3.46e-05	0.00114	CbGpPWpGaD
Etoposide—ABCC1—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	3.42e-05	0.00113	CbGpPWpGaD
Etoposide—PTGS1—Metabolism of lipids and lipoproteins—CHAT—amyotrophic lateral sclerosis	3.41e-05	0.00113	CbGpPWpGaD
Etoposide—GSTP1—Cellular responses to stress—VEGFA—amyotrophic lateral sclerosis	3.38e-05	0.00112	CbGpPWpGaD
Etoposide—ABCG2—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	3.37e-05	0.00111	CbGpPWpGaD
Etoposide—ABCG2—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	3.37e-05	0.00111	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism of lipids and lipoproteins—VAPA—amyotrophic lateral sclerosis	3.37e-05	0.00111	CbGpPWpGaD
Etoposide—PTGS2—Integrated Pancreatic Cancer Pathway—BDNF—amyotrophic lateral sclerosis	3.35e-05	0.00111	CbGpPWpGaD
Etoposide—GSTT1—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	3.34e-05	0.0011	CbGpPWpGaD
Etoposide—PTGS1—Metabolism—VAPA—amyotrophic lateral sclerosis	3.34e-05	0.0011	CbGpPWpGaD
Etoposide—ABCB1—Transmembrane transport of small molecules—TRPM7—amyotrophic lateral sclerosis	3.33e-05	0.0011	CbGpPWpGaD
Etoposide—UGT1A1—Metabolism—DAO—amyotrophic lateral sclerosis	3.24e-05	0.00107	CbGpPWpGaD
Etoposide—ABCG2—Metabolism—SACM1L—amyotrophic lateral sclerosis	3.24e-05	0.00107	CbGpPWpGaD
Etoposide—PTGS2—Integrated Pancreatic Cancer Pathway—PLA2G4A—amyotrophic lateral sclerosis	3.2e-05	0.00106	CbGpPWpGaD
Etoposide—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—amyotrophic lateral sclerosis	3.19e-05	0.00105	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism of lipids and lipoproteins—SACM1L—amyotrophic lateral sclerosis	3.14e-05	0.00104	CbGpPWpGaD
Etoposide—ABCC1—Disease—CHMP2B—amyotrophic lateral sclerosis	3.13e-05	0.00103	CbGpPWpGaD
Etoposide—ABCC1—Metabolism—DAO—amyotrophic lateral sclerosis	3.13e-05	0.00103	CbGpPWpGaD
Etoposide—PTGS1—Metabolism—SACM1L—amyotrophic lateral sclerosis	3.11e-05	0.00103	CbGpPWpGaD
Etoposide—CYP2C8—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	3.08e-05	0.00102	CbGpPWpGaD
Etoposide—TOP2A—Integrated Pancreatic Cancer Pathway—VEGFA—amyotrophic lateral sclerosis	3.06e-05	0.00101	CbGpPWpGaD
Etoposide—ABCG2—Metabolism—FIG4—amyotrophic lateral sclerosis	3.04e-05	0.001	CbGpPWpGaD
Etoposide—CYP2C8—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	3.04e-05	0.001	CbGpPWpGaD
Etoposide—ABCC3—Metabolism—PLB1—amyotrophic lateral sclerosis	3.02e-05	0.000998	CbGpPWpGaD
Etoposide—ABCG2—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	3.01e-05	0.000993	CbGpPWpGaD
Etoposide—CYP1A2—Arachidonic acid metabolism—PTGS2—amyotrophic lateral sclerosis	2.98e-05	0.000985	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism of lipids and lipoproteins—FIG4—amyotrophic lateral sclerosis	2.95e-05	0.000973	CbGpPWpGaD
Etoposide—PTGS1—Metabolism—FIG4—amyotrophic lateral sclerosis	2.92e-05	0.000965	CbGpPWpGaD
Etoposide—CYP2C8—Metabolism of lipids and lipoproteins—PLB1—amyotrophic lateral sclerosis	2.9e-05	0.000959	CbGpPWpGaD
Etoposide—PTGS2—Metabolism—TPK1—amyotrophic lateral sclerosis	2.9e-05	0.000958	CbGpPWpGaD
Etoposide—PTGS2—Metabolism—VAPB—amyotrophic lateral sclerosis	2.9e-05	0.000958	CbGpPWpGaD
Etoposide—ABCC1—Disease—PLB1—amyotrophic lateral sclerosis	2.83e-05	0.000934	CbGpPWpGaD
Etoposide—ABCB1—Integrated Pancreatic Cancer Pathway—CASP9—amyotrophic lateral sclerosis	2.82e-05	0.000931	CbGpPWpGaD
Etoposide—ABCC3—Metabolism—GSR—amyotrophic lateral sclerosis	2.79e-05	0.000921	CbGpPWpGaD
Etoposide—PTGS2—Disease—VTA1—amyotrophic lateral sclerosis	2.77e-05	0.000915	CbGpPWpGaD
Etoposide—ABCG2—Metabolism—DAO—amyotrophic lateral sclerosis	2.75e-05	0.000908	CbGpPWpGaD
Etoposide—GSTT1—Metabolism—APOE—amyotrophic lateral sclerosis	2.75e-05	0.000908	CbGpPWpGaD
Etoposide—CYP2E1—Metabolism—VAPB—amyotrophic lateral sclerosis	2.73e-05	0.000902	CbGpPWpGaD
Etoposide—CYP2E1—Metabolism—TPK1—amyotrophic lateral sclerosis	2.73e-05	0.000902	CbGpPWpGaD
Etoposide—CYP3A5—Metabolism—VAPB—amyotrophic lateral sclerosis	2.73e-05	0.0009	CbGpPWpGaD
Etoposide—CYP3A5—Metabolism—TPK1—amyotrophic lateral sclerosis	2.73e-05	0.0009	CbGpPWpGaD
Etoposide—PTGS2—Metabolism of lipids and lipoproteins—CHAT—amyotrophic lateral sclerosis	2.71e-05	0.000894	CbGpPWpGaD
Etoposide—PTGS2—Metabolism—VAPA—amyotrophic lateral sclerosis	2.65e-05	0.000876	CbGpPWpGaD
Etoposide—PTGS1—Metabolism—DAO—amyotrophic lateral sclerosis	2.64e-05	0.000873	CbGpPWpGaD
Etoposide—GSTP1—Cellular responses to stress—TP53—amyotrophic lateral sclerosis	2.55e-05	0.000842	CbGpPWpGaD
Etoposide—ABCC3—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	2.54e-05	0.000839	CbGpPWpGaD
Etoposide—ABCC1—Disease—VCP—amyotrophic lateral sclerosis	2.52e-05	0.000833	CbGpPWpGaD
Etoposide—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—amyotrophic lateral sclerosis	2.51e-05	0.000829	CbGpPWpGaD
Etoposide—CYP2E1—Metabolism—VAPA—amyotrophic lateral sclerosis	2.5e-05	0.000825	CbGpPWpGaD
Etoposide—CYP3A5—Metabolism—VAPA—amyotrophic lateral sclerosis	2.49e-05	0.000823	CbGpPWpGaD
Etoposide—PTGS2—Metabolism—SACM1L—amyotrophic lateral sclerosis	2.47e-05	0.000815	CbGpPWpGaD
Etoposide—PTGS2—Spinal Cord Injury—CASP3—amyotrophic lateral sclerosis	2.46e-05	0.000813	CbGpPWpGaD
Etoposide—UGT1A1—Metabolism—PLB1—amyotrophic lateral sclerosis	2.46e-05	0.000811	CbGpPWpGaD
Etoposide—ABCB1—Allograft Rejection—CASP3—amyotrophic lateral sclerosis	2.41e-05	0.000794	CbGpPWpGaD
Etoposide—ABCB1—Integrated Pancreatic Cancer Pathway—BDNF—amyotrophic lateral sclerosis	2.38e-05	0.000785	CbGpPWpGaD
Etoposide—ABCC1—Metabolism—PLB1—amyotrophic lateral sclerosis	2.37e-05	0.000782	CbGpPWpGaD
Etoposide—CYP2C8—Metabolism—VAPB—amyotrophic lateral sclerosis	2.36e-05	0.00078	CbGpPWpGaD
Etoposide—CYP2C8—Metabolism—TPK1—amyotrophic lateral sclerosis	2.36e-05	0.00078	CbGpPWpGaD
Etoposide—ABCB1—HIF-1-alpha transcription factor network—VEGFA—amyotrophic lateral sclerosis	2.36e-05	0.000778	CbGpPWpGaD
Etoposide—PTGS2—Spinal Cord Injury—MMP9—amyotrophic lateral sclerosis	2.33e-05	0.000768	CbGpPWpGaD
Etoposide—CYP2E1—Metabolism—SACM1L—amyotrophic lateral sclerosis	2.32e-05	0.000767	CbGpPWpGaD
Etoposide—PTGS2—Metabolism—FIG4—amyotrophic lateral sclerosis	2.32e-05	0.000766	CbGpPWpGaD
Etoposide—CYP3A5—Metabolism—SACM1L—amyotrophic lateral sclerosis	2.32e-05	0.000765	CbGpPWpGaD
Etoposide—TOP2A—Integrated Pancreatic Cancer Pathway—TP53—amyotrophic lateral sclerosis	2.31e-05	0.000763	CbGpPWpGaD
Etoposide—ABCC3—Metabolism—CHAT—amyotrophic lateral sclerosis	2.29e-05	0.000757	CbGpPWpGaD
Etoposide—ABCB1—Integrated Pancreatic Cancer Pathway—PLA2G4A—amyotrophic lateral sclerosis	2.27e-05	0.000749	CbGpPWpGaD
Etoposide—UGT1A1—Metabolism—GSR—amyotrophic lateral sclerosis	2.27e-05	0.000749	CbGpPWpGaD
Etoposide—TOP2A—Circadian rythm related genes—TP53—amyotrophic lateral sclerosis	2.22e-05	0.000733	CbGpPWpGaD
Etoposide—CYP2C8—Metabolism of lipids and lipoproteins—CHAT—amyotrophic lateral sclerosis	2.2e-05	0.000727	CbGpPWpGaD
Etoposide—ABCC1—Metabolism—GSR—amyotrophic lateral sclerosis	2.19e-05	0.000722	CbGpPWpGaD
Etoposide—CYP2E1—Metabolism—FIG4—amyotrophic lateral sclerosis	2.18e-05	0.000721	CbGpPWpGaD
Etoposide—CYP3A5—Metabolism—FIG4—amyotrophic lateral sclerosis	2.18e-05	0.00072	CbGpPWpGaD
Etoposide—PTGS2—Integrated Pancreatic Cancer Pathway—IGF1—amyotrophic lateral sclerosis	2.18e-05	0.000719	CbGpPWpGaD
Etoposide—CYP2C8—Metabolism—VAPA—amyotrophic lateral sclerosis	2.16e-05	0.000713	CbGpPWpGaD
Etoposide—ABCB1—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	2.14e-05	0.000708	CbGpPWpGaD
Etoposide—CYP1A2—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	2.14e-05	0.000708	CbGpPWpGaD
Etoposide—CYP1A2—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	2.11e-05	0.000698	CbGpPWpGaD
Etoposide—PTGS2—Disease—CHMP2B—amyotrophic lateral sclerosis	2.1e-05	0.000693	CbGpPWpGaD
Etoposide—PTGS2—Metabolism—DAO—amyotrophic lateral sclerosis	2.1e-05	0.000693	CbGpPWpGaD
Etoposide—ABCC3—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	2.09e-05	0.00069	CbGpPWpGaD
Etoposide—ABCG2—Metabolism—PLB1—amyotrophic lateral sclerosis	2.08e-05	0.000688	CbGpPWpGaD
Etoposide—ABCB1—Metabolism—VAPB—amyotrophic lateral sclerosis	2.06e-05	0.000679	CbGpPWpGaD
Etoposide—ABCB1—Metabolism—TPK1—amyotrophic lateral sclerosis	2.06e-05	0.000679	CbGpPWpGaD
Etoposide—ABCB1—Allograft Rejection—VEGFA—amyotrophic lateral sclerosis	2.04e-05	0.000674	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism of lipids and lipoproteins—PLB1—amyotrophic lateral sclerosis	2.02e-05	0.000667	CbGpPWpGaD
Etoposide—CYP2C8—Metabolism—SACM1L—amyotrophic lateral sclerosis	2.01e-05	0.000663	CbGpPWpGaD
Etoposide—PTGS1—Metabolism—PLB1—amyotrophic lateral sclerosis	2e-05	0.000661	CbGpPWpGaD
Etoposide—ABCC1—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	1.99e-05	0.000658	CbGpPWpGaD
Etoposide—CYP2E1—Metabolism—DAO—amyotrophic lateral sclerosis	1.97e-05	0.000652	CbGpPWpGaD
Etoposide—CYP3A5—Metabolism—DAO—amyotrophic lateral sclerosis	1.97e-05	0.000651	CbGpPWpGaD
Etoposide—ABCG2—Metabolism—GSR—amyotrophic lateral sclerosis	1.92e-05	0.000635	CbGpPWpGaD
Etoposide—PTGS2—Disease—PLB1—amyotrophic lateral sclerosis	1.9e-05	0.000627	CbGpPWpGaD
Etoposide—CYP2C8—Metabolism—FIG4—amyotrophic lateral sclerosis	1.89e-05	0.000623	CbGpPWpGaD
Etoposide—GSTT1—Metabolism—PTGS2—amyotrophic lateral sclerosis	1.88e-05	0.000622	CbGpPWpGaD
Etoposide—ABCB1—Metabolism—VAPA—amyotrophic lateral sclerosis	1.88e-05	0.000621	CbGpPWpGaD
Etoposide—UGT1A1—Metabolism—CHAT—amyotrophic lateral sclerosis	1.86e-05	0.000615	CbGpPWpGaD
Etoposide—PTGS1—Metabolism—GSR—amyotrophic lateral sclerosis	1.85e-05	0.00061	CbGpPWpGaD
Etoposide—GSTP1—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	1.83e-05	0.000605	CbGpPWpGaD
Etoposide—ABCB1—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	1.82e-05	0.000602	CbGpPWpGaD
Etoposide—ABCB1—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	1.82e-05	0.000602	CbGpPWpGaD
Etoposide—ABCC1—Disease—CST3—amyotrophic lateral sclerosis	1.81e-05	0.000598	CbGpPWpGaD
Etoposide—ABCC1—Metabolism—CHAT—amyotrophic lateral sclerosis	1.8e-05	0.000593	CbGpPWpGaD
Etoposide—ABCB1—Metabolism—SACM1L—amyotrophic lateral sclerosis	1.75e-05	0.000578	CbGpPWpGaD
Etoposide—CYP2C8—Metabolism—DAO—amyotrophic lateral sclerosis	1.71e-05	0.000564	CbGpPWpGaD
Etoposide—PTGS2—Disease—VCP—amyotrophic lateral sclerosis	1.69e-05	0.000559	CbGpPWpGaD
Etoposide—PTGS1—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	1.68e-05	0.000556	CbGpPWpGaD
Etoposide—PTGS2—Integrated Pancreatic Cancer Pathway—CASP3—amyotrophic lateral sclerosis	1.67e-05	0.000553	CbGpPWpGaD
Etoposide—CYP3A4—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	1.65e-05	0.000546	CbGpPWpGaD
Etoposide—ABCB1—Metabolism—FIG4—amyotrophic lateral sclerosis	1.64e-05	0.000543	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism—TPK1—amyotrophic lateral sclerosis	1.64e-05	0.000542	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism—VAPB—amyotrophic lateral sclerosis	1.64e-05	0.000542	CbGpPWpGaD
Etoposide—ABCC1—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	1.64e-05	0.000541	CbGpPWpGaD
Etoposide—CYP3A4—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	1.63e-05	0.000539	CbGpPWpGaD
Etoposide—ABCB1—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	1.63e-05	0.000537	CbGpPWpGaD
Etoposide—PTGS2—Metabolism—PLB1—amyotrophic lateral sclerosis	1.59e-05	0.000525	CbGpPWpGaD
Etoposide—ABCG2—Metabolism—CHAT—amyotrophic lateral sclerosis	1.58e-05	0.000522	CbGpPWpGaD
Etoposide—PTGS2—Spinal Cord Injury—TP53—amyotrophic lateral sclerosis	1.58e-05	0.000521	CbGpPWpGaD
Etoposide—ABCB1—Integrated Pancreatic Cancer Pathway—IGF1—amyotrophic lateral sclerosis	1.54e-05	0.000509	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism of lipids and lipoproteins—CHAT—amyotrophic lateral sclerosis	1.53e-05	0.000506	CbGpPWpGaD
Etoposide—PTGS1—Metabolism—CHAT—amyotrophic lateral sclerosis	1.52e-05	0.000501	CbGpPWpGaD
Etoposide—GSTP1—Metabolism—APOE—amyotrophic lateral sclerosis	1.51e-05	0.000498	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism—VAPA—amyotrophic lateral sclerosis	1.5e-05	0.000496	CbGpPWpGaD
Etoposide—CYP2E1—Metabolism—PLB1—amyotrophic lateral sclerosis	1.5e-05	0.000494	CbGpPWpGaD
Etoposide—CYP3A5—Metabolism—PLB1—amyotrophic lateral sclerosis	1.49e-05	0.000493	CbGpPWpGaD
Etoposide—ABCB1—Metabolism—DAO—amyotrophic lateral sclerosis	1.49e-05	0.000491	CbGpPWpGaD
Etoposide—PTGS2—Metabolism—GSR—amyotrophic lateral sclerosis	1.47e-05	0.000485	CbGpPWpGaD
Etoposide—ABCC3—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	1.43e-05	0.000473	CbGpPWpGaD
Etoposide—PTGS2—Integrated Pancreatic Cancer Pathway—VEGFA—amyotrophic lateral sclerosis	1.42e-05	0.000469	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism—SACM1L—amyotrophic lateral sclerosis	1.4e-05	0.000461	CbGpPWpGaD
Etoposide—PTGS1—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	1.38e-05	0.000457	CbGpPWpGaD
Etoposide—CYP2E1—Metabolism—GSR—amyotrophic lateral sclerosis	1.38e-05	0.000456	CbGpPWpGaD
Etoposide—CYP3A5—Metabolism—GSR—amyotrophic lateral sclerosis	1.38e-05	0.000455	CbGpPWpGaD
Etoposide—PTGS2—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	1.34e-05	0.000441	CbGpPWpGaD
Etoposide—ABCC1—Disease—CASP9—amyotrophic lateral sclerosis	1.32e-05	0.000435	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism—FIG4—amyotrophic lateral sclerosis	1.31e-05	0.000434	CbGpPWpGaD
Etoposide—CYP2C8—Metabolism—PLB1—amyotrophic lateral sclerosis	1.29e-05	0.000427	CbGpPWpGaD
Etoposide—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—amyotrophic lateral sclerosis	1.28e-05	0.000422	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—TPK1—amyotrophic lateral sclerosis	1.27e-05	0.000419	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—VAPB—amyotrophic lateral sclerosis	1.27e-05	0.000419	CbGpPWpGaD
Etoposide—ABCC3—Metabolism—GSTP1—amyotrophic lateral sclerosis	1.23e-05	0.000407	CbGpPWpGaD
Etoposide—PTGS2—Disease—CST3—amyotrophic lateral sclerosis	1.21e-05	0.000401	CbGpPWpGaD
Etoposide—PTGS2—Metabolism—CHAT—amyotrophic lateral sclerosis	1.2e-05	0.000398	CbGpPWpGaD
Etoposide—CYP2C8—Metabolism—GSR—amyotrophic lateral sclerosis	1.19e-05	0.000394	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism—DAO—amyotrophic lateral sclerosis	1.19e-05	0.000392	CbGpPWpGaD
Etoposide—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—amyotrophic lateral sclerosis	1.19e-05	0.000392	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—VAPA—amyotrophic lateral sclerosis	1.16e-05	0.000383	CbGpPWpGaD
Etoposide—CYP2E1—Metabolism—CHAT—amyotrophic lateral sclerosis	1.13e-05	0.000375	CbGpPWpGaD
Etoposide—CYP3A5—Metabolism—CHAT—amyotrophic lateral sclerosis	1.13e-05	0.000374	CbGpPWpGaD
Etoposide—ABCC3—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	1.13e-05	0.000374	CbGpPWpGaD
Etoposide—ABCB1—Metabolism—PLB1—amyotrophic lateral sclerosis	1.13e-05	0.000372	CbGpPWpGaD
Etoposide—ABCC1—Disease—ERBB4—amyotrophic lateral sclerosis	1.13e-05	0.000372	CbGpPWpGaD
Etoposide—ABCC1—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	1.12e-05	0.000371	CbGpPWpGaD
Etoposide—PTGS2—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	1.1e-05	0.000363	CbGpPWpGaD
Etoposide—CYP2C8—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	1.09e-05	0.000359	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—SACM1L—amyotrophic lateral sclerosis	1.08e-05	0.000356	CbGpPWpGaD
Etoposide—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—amyotrophic lateral sclerosis	1.07e-05	0.000355	CbGpPWpGaD
Etoposide—ABCB1—Metabolism—GSR—amyotrophic lateral sclerosis	1.04e-05	0.000343	CbGpPWpGaD
Etoposide—GSTP1—Metabolism—PTGS2—amyotrophic lateral sclerosis	1.03e-05	0.000341	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—FIG4—amyotrophic lateral sclerosis	1.01e-05	0.000335	CbGpPWpGaD
Etoposide—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—amyotrophic lateral sclerosis	1.01e-05	0.000333	CbGpPWpGaD
Etoposide—UGT1A1—Metabolism—GSTP1—amyotrophic lateral sclerosis	1e-05	0.00033	CbGpPWpGaD
Etoposide—TOP2A—Cell Cycle—TP53—amyotrophic lateral sclerosis	1e-05	0.00033	CbGpPWpGaD
Etoposide—CYP2C8—Metabolism—CHAT—amyotrophic lateral sclerosis	9.8e-06	0.000324	CbGpPWpGaD
Etoposide—ABCC1—Metabolism—GSTP1—amyotrophic lateral sclerosis	9.65e-06	0.000319	CbGpPWpGaD
Etoposide—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	9.49e-06	0.000313	CbGpPWpGaD
Etoposide—ABCC3—Metabolism—APOE—amyotrophic lateral sclerosis	9.31e-06	0.000307	CbGpPWpGaD
Etoposide—UGT1A1—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	9.2e-06	0.000304	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—DAO—amyotrophic lateral sclerosis	9.16e-06	0.000303	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism—PLB1—amyotrophic lateral sclerosis	9e-06	0.000297	CbGpPWpGaD
Etoposide—CYP2C8—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	8.95e-06	0.000295	CbGpPWpGaD
Etoposide—ABCC1—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	8.87e-06	0.000293	CbGpPWpGaD
Etoposide—PTGS2—Disease—CASP9—amyotrophic lateral sclerosis	8.83e-06	0.000292	CbGpPWpGaD
Etoposide—ABCC1—Disease—APOE—amyotrophic lateral sclerosis	8.71e-06	0.000288	CbGpPWpGaD
Etoposide—ABCB1—Metabolism—CHAT—amyotrophic lateral sclerosis	8.54e-06	0.000282	CbGpPWpGaD
Etoposide—ABCG2—Metabolism—GSTP1—amyotrophic lateral sclerosis	8.49e-06	0.00028	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism—GSR—amyotrophic lateral sclerosis	8.3e-06	0.000274	CbGpPWpGaD
Etoposide—PTGS1—Metabolism—GSTP1—amyotrophic lateral sclerosis	8.16e-06	0.000269	CbGpPWpGaD
Etoposide—ABCG2—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	7.8e-06	0.000258	CbGpPWpGaD
Etoposide—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—amyotrophic lateral sclerosis	7.61e-06	0.000251	CbGpPWpGaD
Etoposide—UGT1A1—Metabolism—APOE—amyotrophic lateral sclerosis	7.57e-06	0.00025	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	7.56e-06	0.00025	CbGpPWpGaD
Etoposide—PTGS2—Disease—ERBB4—amyotrophic lateral sclerosis	7.56e-06	0.00025	CbGpPWpGaD
Etoposide—PTGS1—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	7.5e-06	0.000248	CbGpPWpGaD
Etoposide—ABCC1—Metabolism—APOE—amyotrophic lateral sclerosis	7.3e-06	0.000241	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—PLB1—amyotrophic lateral sclerosis	6.94e-06	0.000229	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism—CHAT—amyotrophic lateral sclerosis	6.82e-06	0.000225	CbGpPWpGaD
Etoposide—PTGS2—Metabolism—GSTP1—amyotrophic lateral sclerosis	6.48e-06	0.000214	CbGpPWpGaD
Etoposide—ABCG2—Metabolism—APOE—amyotrophic lateral sclerosis	6.42e-06	0.000212	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—GSR—amyotrophic lateral sclerosis	6.41e-06	0.000212	CbGpPWpGaD
Etoposide—ABCC3—Metabolism—PTGS2—amyotrophic lateral sclerosis	6.38e-06	0.000211	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	6.22e-06	0.000205	CbGpPWpGaD
Etoposide—PTGS1—Metabolism—APOE—amyotrophic lateral sclerosis	6.17e-06	0.000204	CbGpPWpGaD
Etoposide—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	6.13e-06	0.000202	CbGpPWpGaD
Etoposide—CYP2E1—Metabolism—GSTP1—amyotrophic lateral sclerosis	6.1e-06	0.000201	CbGpPWpGaD
Etoposide—CYP3A5—Metabolism—GSTP1—amyotrophic lateral sclerosis	6.08e-06	0.000201	CbGpPWpGaD
Etoposide—ABCC1—Disease—PTGS2—amyotrophic lateral sclerosis	5.97e-06	0.000197	CbGpPWpGaD
Etoposide—PTGS2—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	5.95e-06	0.000197	CbGpPWpGaD
Etoposide—PTGS2—Disease—APOE—amyotrophic lateral sclerosis	5.85e-06	0.000193	CbGpPWpGaD
Etoposide—CYP2E1—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	5.6e-06	0.000185	CbGpPWpGaD
Etoposide—CYP3A5—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	5.59e-06	0.000185	CbGpPWpGaD
Etoposide—CYP2C8—Metabolism—GSTP1—amyotrophic lateral sclerosis	5.27e-06	0.000174	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—CHAT—amyotrophic lateral sclerosis	5.26e-06	0.000174	CbGpPWpGaD
Etoposide—UGT1A1—Metabolism—PTGS2—amyotrophic lateral sclerosis	5.18e-06	0.000171	CbGpPWpGaD
Etoposide—ABCC1—Metabolism—PTGS2—amyotrophic lateral sclerosis	5e-06	0.000165	CbGpPWpGaD
Etoposide—PTGS2—Metabolism—APOE—amyotrophic lateral sclerosis	4.9e-06	0.000162	CbGpPWpGaD
Etoposide—CYP2C8—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	4.84e-06	0.00016	CbGpPWpGaD
Etoposide—CYP2E1—Metabolism—APOE—amyotrophic lateral sclerosis	4.61e-06	0.000152	CbGpPWpGaD
Etoposide—CYP3A5—Metabolism—APOE—amyotrophic lateral sclerosis	4.6e-06	0.000152	CbGpPWpGaD
Etoposide—ABCB1—Metabolism—GSTP1—amyotrophic lateral sclerosis	4.59e-06	0.000152	CbGpPWpGaD
Etoposide—ABCG2—Metabolism—PTGS2—amyotrophic lateral sclerosis	4.4e-06	0.000145	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	4.26e-06	0.000141	CbGpPWpGaD
Etoposide—PTGS1—Metabolism—PTGS2—amyotrophic lateral sclerosis	4.23e-06	0.00014	CbGpPWpGaD
Etoposide—ABCB1—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	4.22e-06	0.000139	CbGpPWpGaD
Etoposide—CYP2C8—Metabolism—APOE—amyotrophic lateral sclerosis	3.98e-06	0.000132	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism—GSTP1—amyotrophic lateral sclerosis	3.66e-06	0.000121	CbGpPWpGaD
Etoposide—ABCB1—Metabolism—APOE—amyotrophic lateral sclerosis	3.47e-06	0.000115	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	3.37e-06	0.000111	CbGpPWpGaD
Etoposide—CYP2E1—Metabolism—PTGS2—amyotrophic lateral sclerosis	3.16e-06	0.000104	CbGpPWpGaD
Etoposide—CYP3A5—Metabolism—PTGS2—amyotrophic lateral sclerosis	3.15e-06	0.000104	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—GSTP1—amyotrophic lateral sclerosis	2.83e-06	9.34e-05	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism—APOE—amyotrophic lateral sclerosis	2.77e-06	9.15e-05	CbGpPWpGaD
Etoposide—CYP2C8—Metabolism—PTGS2—amyotrophic lateral sclerosis	2.73e-06	9.02e-05	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	2.6e-06	8.58e-05	CbGpPWpGaD
Etoposide—ABCB1—Metabolism—PTGS2—amyotrophic lateral sclerosis	2.38e-06	7.85e-05	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—APOE—amyotrophic lateral sclerosis	2.14e-06	7.06e-05	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism—PTGS2—amyotrophic lateral sclerosis	1.9e-06	6.27e-05	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—PTGS2—amyotrophic lateral sclerosis	1.47e-06	4.84e-05	CbGpPWpGaD
